ð¥ 5ç§ã®å£°ã§å¿äžå šããããïŒïœNoah LabsãVoxããå€ãããã«ã¹ã±ã¢ã®æªæ¥

ã¢ã€
ç®æ¬¡
- ã声ãé²é³ããã ããã§ç æ°ããããæä»£ãæ¥ã
- ããèãã3ã€ã®çç±
- ãŸãšãïŒAIãã«ã¹ã±ã¢ãã€ãã«å®ç𿮵éã«å ¥ã£ã
ã声ãé²é³ããã ããã§ç æ°ããããæä»£ãæ¥ã
ãããæåã«èãããšãããã£ããããªããšã§ããã®ïŒãã£ãŠãªã£ããã ãã©ãããžãªã® ð³
ã¹ã€ã¹ã®ã¹ã¿ãŒãã¢ããNoah Labsãäœã£ããVoxãã£ãŠããAIãããã£ã5ç§ã®é³å£°é²é³ããå¿äžå šã®æªåãæ€ç¥ã§ãããããããããFDAïŒã¢ã¡ãªã«é£åå»è¬åå±ïŒããç»æçããã€ã¹ããšããŠèªãã¡ãã£ãã
å¿äžå šã£ãŠæ¥æ¬ã§ãæ£è æ°120äžäººä»¥äžããŠãé«éœ¢åã§ã©ãã©ãå¢ããŠããã ãããä»ãŸã§å¿äžå šã®ã¢ãã¿ãªã³ã°ã£ãŠå®æçã«ç é¢è¡ã£ãŠæ€æ»ãããããªãã£ããã©ãã¹ããã§å£°ãé²é³ããã ãã§æ¯æ¥ãã§ãã¯ã§ããããã«ãªã£ããïŒãããããããã¡ã®å®¶æã«ãé¢ä¿ããŠãã話ã ãã
ããèãã3ã€ã®çç±
300äžã®é³å£°ãµã³ãã«ã§èšç·ŽãããAI
Voxã®ããããšããã¯ãããŒã¿éããã³ããªãããšã300äžä»¥äžã®é³å£°ãµã³ãã«ã§èšç·ŽãããŠãŠã声ã®äžã«å«ãŸãããèºãã£è¡ãããäœæ¶²éå€ãã®ãµã€ã³ãæ€åºããã¢ã«ãŽãªãºã ãéçºããŠãã
人éã®å£°ã£ãŠãäœã®ç¶æ ã§åŸ®åŠã«å€ãããããã®ãèºã«æ°ŽãæºãŸããšå£°ã®åšæ³¢æ°ãã¿ãŒã³ãå€ãããããããã¡ã«ã¯èãåããªããã©ãAIãªããããã5ç§ã®é²é³ã§ãæ¯æ¥ã®äœèª¿å€åããã©ããã³ã°ã§ãã ð€
ããã£ãŠã€ãŸããããªãã仿¥å£°ããããããªãã¬ãã«ã®å€åããAIãæ°å€åããŠãç é¢è¡ã£ãã»ããããã§ãããã£ãŠæããŠãããã£ãŠããšã
ãœãŒã¹: Noah Labs lands FDA breakthrough designation for AI voice-based heart failure monitor
Mayo Clinicãªã©äžçãããç é¢ãèšåºæ€èšŒæžã¿
ãAIãç æ°ãèŠã€ããŸããã£ãŠèšãã ããªã誰ã§ãã§ãããã§ãNoah Labsã¯ãMayo ClinicïŒã¡ã€ãšãŒã¯ãªããã¯ïŒãUCSFïŒã«ãªãã©ã«ãã¢å€§åŠãµã³ãã©ã³ã·ã¹ã³æ ¡ïŒããã«ãªã³ã»ã·ã£ãªããããŒã¹ããªãã倧åŠå»çã»ã³ã¿ãŒããã«ã»ããç é¢ã¯ãªããã¯ã£ãŠãããäžçã§ããããã¯ã©ã¹ã®å»çæ©é¢ãšå ±åã§èšåºæ€èšŒããã£ãŠã ð¥
FDAã®ãç»æçããã€ã¹æå®ãã£ãŠãããç°¡åã«ã¯ããããªãã®ãæ¢åã®æ²»çæ³ããæç¢ºã«åªããŠããå¯èœæ§ãããã£ãŠèªããããã£ãŠããšãæ¿èªããã»ã¹ãéåžžããæ©ãé²ããããã¢ã¡ãªã«ã§ã®å®çšåã¯ããªãè¿ãã¯ãã
EUæ¿èªã2026幎äžç€ãèŠèŸŒãã§ãŠãæ©ããã°å¹Žå ã«ãšãŒãããã§ã䜿ããããã«ãªãããã
ãœãŒã¹: FDA sees promise in voice-based AI model for heart failure
ã¹ãã1å°ã§æ¯æ¥ã¢ãã¿ãªã³ã°ã§ããæªæ¥
å¿äžå šã®ã¢ãã¿ãªã³ã°ã£ãŠãä»ã¯èžã«ã»ã³ãµãŒè²Œã£ããã宿çã«ç é¢ã§è¡æ¶²æ€æ»ãå¿ãšã³ãŒãããããå¿ èŠããããé«éœ¢ã®æ£è ããã«ã¯çµæ§ãªè² æ ã ããã
ã§ãVoxãªããæ¯æã¹ããã«åãã£ãŠ5ç§è©±ãã ãããŠã§ã¢ã©ãã«ããã€ã¹ã¿ããã«å é»ãããè£ çãããããæéããªããããã£ãŠã誰ã§ã䜿ãããã£ãŠããAIãã«ã¹ã±ã¢ã®çæ³åœ¢ã«è¿ã ð±
ããããã®æè¡ãå¿äžå šã ããããªããŠä»ã®çŸæ£ã«ãå¿çšã§ããå¯èœæ§ãããã声ã®ãã¿ãŒã³å€åã§åŒåžåšçŸæ£ãã¡ã³ã¿ã«ãã«ã¹ã®å åãæããç ç©¶ãé²ãã§ããããå°æ¥çã«ã¯ãæ¯æã®é³å£°ãã§ãã¯ã§å šèº«ã¹ã¯ãªãŒãã³ã°ããªããŠããšã«ãªãããã
ãœãŒã¹: NL Vox - Noah Labs
ãŸãšãïŒAIãã«ã¹ã±ã¢ãã€ãã«å®ç𿮵éã«å ¥ã£ã
Noah Labs Voxã¯ããAIã§å¥åº·ç®¡çãã倢ç©èªãããªããªã£ãããšã瀺ã倧ããªäžæ©ã5ç§ã®å£°ããå¿äžå šãæ€ç¥ããã£ãŠãæ°å¹Žåãªã誰ãä¿¡ããªãã£ããšæãã
AIãã«ã¹ã±ã¢ã£ãŠãããããã ãã©å®é䜿ããã®ïŒãã£ãŠæ®µéããã£ãšç¶ããŠããã©ãFDAç»æçããã€ã¹æå®ãåã£ãããšã§ãããããå®çšã®ãã§ãŒãºã«å ¥ã£ããèªåãå®¶æã®å¥åº·ç®¡çããAIã§ãã£ãšç°¡åã«ãªãæ¥ã¯ããé ããªãã âš
é¢é£èšäº:
- ChatGPT vs Gemini vs Claude åŸ¹åºæ¯èŒïœä»äºã§äœ¿ããªãã©ãããã¹ãïŒ
- 2026幎çïœå®éã«äœ¿ã£ãŠæ¯èŒïŒAIä»äºå¹çåããŒã«5éž
- Microsoftãæ¥æ¬ã«100åãã«ã®AIæè³ïœæ¥æ¬ã®AIç£æ¥ã¯å€ããã®ã
- OpenAI 1,220åãã«èª¿éã®è¡æïœAIæ¥çã«äœãèµ·ããã®ã
- AIã§å¯æ¥ãå§ããæ¹æ³5éžïœæ5äžåãç®æãåå¿è ããŒãããã
- Gemma 4ãApache 2.0ã§ç»å ŽïœãªãŒãã³ãœãŒã¹AIé©åœã®æ°ç«
- 声ãé²é³ããã ãã§å¿äžå šããããïŒïœNoah Labs VoxãšFDAèªå®ã®ææ°æ å ±
- Anthropicã補è¬ã«åå ¥ããïœAIäŒæ¥ã®ãæ¬¡ã®æŠå Žãã¯å»è¬åéçº
- AIãè¬ãåŠæ¹ããæä»£ãæ¥ãïœãŠã¿å·ã®å®éšãšå»çã®æªæ¥
- Macy'sã®AIã·ã§ããã³ã°ã¢ã·ã¹ã¿ã³ãã売äžãå€ãã
- ã¯ã©ãŠãäŒèšãœããæ¯èŒ 2026幎ç
ãœãŒã¹:
- Noah Labs lands FDA breakthrough designation
- FDA sees promise in voice-based AI model for heart failure
- NL Vox - Noah Labs
ãããã質å
- ãã®èšäºã¯ã©ããªå 容ã§ããïŒ
- Noah Labsã®AIé³å£°èšºæããŒã«ãVoxããFDAç»æçããã€ã¹æå®ãååŸã5ç§ã®å£°ã§å¿äžå šãæ€ç¥ããæè¡ã®ä»çµã¿ãšããããã¡ãžã®åœ±é¿ã解説ã
- æ å ±ã¯ãã€æç¹ã®ãã®ã§ããïŒ
- 2026-04-04 æç¹ã§ãŸãšããæ å ±ã§ãïŒ2026-04 ã®ååïŒãAIé¢é£ã®åãã¯éããææ°ç¶æ³ã¯å€åããå¯èœæ§ããããããå ¬åŒçºè¡šãäžæ¬¡ãœãŒã¹ãããããŠç¢ºèªããŠãã ããã
- èªè ãšããŠã©ãåãæ¢ããã°ããã§ããïŒ
- æ¬èšäºã¯ãäžéã®èŠæ¹ããçè ã®èŠè§£ããããŒã¿ã»äºå®ããããããèããŠããããã¢ã¯ã·ã§ã³ãã®æµãã§æŽçããŠããŸããAIããŒã«ã®äœ¿ãæ¹ãä»äºã®ããæ¹ã«é¢ããåããšããŠãèªåã®ç¶æ³ã«çœ®ãæããŠèªãã§ã¿ãŠãã ããã